Point-of-care Molecular Diagnostics Market
Point-of-care Molecular Diagnostics is an Innovation in the Healthcare Sector to Detect Patients Infectious Condition Faster. FMI Analyzes More Trends with the United States, China, and 30+ Countries
Point-of-care Molecular Diagnostics Market by Products & Services, Technology, Application, End User, & Region | Forecast 2023 to 2033
Point-of-care Molecular Diagnostics Market Outlook (2023 to 2033)
The point-of-care molecular diagnostics market is estimated to capture a valuation of US$ 4.4 billion in 2023 and is rising to US$ 11.1 billion by 2033. The market is predicted at a CAGR of 9.7% during the forecast period.
Point-of-care Molecular Diagnostics Market – Driving Factors
- The rising prevalence of chronic and infectious diseases increases the demand for point-of-care molecular diagnostics.
- Healthcare manufacturers are expanding the laboratory sector due to the growing adoption of point-of-care molecular diagnostics.
- Rising high costs for testing, delays in results, and time-consuming methods are accelerating the demand for point-of-care molecular diagnostics.
- Increasing diagnostic tests and preventive medicine are boosting the demand for point-of-care molecular diagnostics.
- Adopting modern techniques and improving knowledge-related molecular mechanisms drive market growth.
- Growing demand for point-of-care molecular diagnostics for DNA sequencing and multi-gene examination is booming the market growth.
- Fast and accurate results and rapid detection of diseases are increasing the sales of point-of-care molecular diagnostics.
- Adopting point-of-care molecular diagnostics to detect gastrointestinal disorders and respiratory and sexually transmitted diseases is propelling the market expansion.
- Growing patient awareness and adoption in emerging economies are fuelling market opportunities.
- Advanced development of microfluidics, government initiatives, and point-of-care molecular diagnostics manufacturers are surging market opportunities.
Let us know your requirement to get
100% FREE customization
Factors Limit the Growth of the Point-of-care Molecular Diagnostics Market
Lack of awareness about health and healthcare products in developing countries limits market growth. The absence of reimbursement policies and poor penetration of advanced healthcare devices further hinder the market growth in a few regions.
Emerging Growth Opportunities in the Developing Countries
Manufacturers in developing countries such as India, South Korea, and Brazil significantly produce point-of-care molecular diagnostics. Growing patients population, testing products, advanced healthcare infrastructure, and rising infectious diseases are advancing the market opportunities.
|
Attributes |
Details |
|
Market CAGR (2023 to 2033) |
9.7% |
|
Market Valuation (2023) |
US$ 4.4 billion |
|
Market Valuation (2033) |
US$ 11.1 billion |
Point-of-care Molecular Diagnostics Market, 2017 to 2022 Historical Sales, Compared to 2023 to 2033 Future Outlook
According to Future Market Insights, the global point-of-care molecular diagnostics market is predicted at a healthy 9.7% CAGR during the forecast period. Historically, the market registered a CAGR of 10.4%&between 2017 and 2022.
Increased prevalence of infectious diseases, research and development activities, and early detection of infectious diseases are the factors driving the market growth globally. Apart from these factors, increasingly advanced commercialized technology, diagnostic alternatives, and improved therapeutic are growing the demand for point-of-care molecular diagnostics.&
Adopting point-of-care molecular diagnostics to identify gene expression in molecular biology fosters market growth. In the recent period, healthcare physicians have improved the standard of testing with the ability of quick testing, which consequently increases the demand for point-of-care diagnostics. In 2022, according to the American Cancer Society, around 1.9 million new cancer cases were recorded in the United States.
- Short Term (2023 to 2026):&Increasing chronic and infectious patients and rising high costs of testing accelerating the demand for point-of-care molecular diagnostics.
- Medium Term (2026 to 2029):&Rising modern technologies, quick results for testing, and improving knowledge-related molecular mechanisms are expanding market growth.
- Long Term (2029 to 2033):&Government initiatives, research and development activities, growing economies, and patient awareness-related healthcare advancing market opportunities.
The market is estimated to reach US$ 11.1 billion during the forecast period. Historically, the market stood at US$ 3.4 billion from 2017 to 2022.&
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystComparative Analysis of Adjacent Markets
Point-of-care Molecular Diagnostics Market:
|
Attributes |
Point-of-care Molecular Diagnostics Market |
|
CAGR (2023 to 2033) |
9.7% |
|
Value (2023) |
US$ 4.4 billion |
|
Value (2033) |
US$ 11.1 billion |
|
Trends |
Adopting modern techniques and improving knowledge-related molecular mechanisms drive market growth. |
|
Opportunities |
Rising patient awareness, growing economies, and low-cost point-of-care molecular diagnostics are driving market opportunities. |
Clinical Diagnostics Market:
|
Attributes |
Clinical Diagnostics Market |
|
CAGR (2023 to 2033) |
6.1% |
|
Value (2023) |
US$ 78.51 billion |
|
Value (2033) |
US$ 141.93 billion |
|
Trends |
Increasing demand for collecting samples, blood test, and other are accelerating the demand for clinical diagnostics. |
|
Opportunities |
High investment, rising chronic diseases, and innovations with advanced technology |
Infectious Disease Diagnostic Market:
|
Attributes |
Infectious Disease Diagnostic Market |
|
CAGR (2023 to 2033) |
6.4% |
|
Value (2023) |
US$ 28.07 billion |
|
Value (2033) |
US$ 33.81 billion |
|
Trends |
Rising laboratory tests, infectious diseases, and skilled technicians |
|
Opportunities |
Government initiatives, high-technology products, and urbanization |
Top Two Segments in the Market
| Segments |
Product and Services |
| Top Category |
Assays & Kits |
| Historic CAGR |
10.2% |
| Forecast CAGR |
10% |
| Segments |
Technology |
| Top Category |
RT-PCR |
| Historic CAGR |
9.6% |
| Forecast CAGR |
9.2% |
Which Product & Service Segment Leads the Market?
Based on products & services, assays & kits are leading the global market by capturing a CAGR of 10% during the forecast period. The growing adoption of assays &kits&products by several end-use industries is surging the market growth. The increasing adoption of assays & kits due to quick and accurate testing is further fueling the market expansion.
Growing demand for assays & kits in the laboratory to research drugs, science life, and environment monitoring is propelling market opportunities. Historically, the assays & kits captured a CAGR of 10.2% between 2017 and 2022.
Which Application Contributes a Lucrative Growth in the Market?
Based on application, respiratory diseases are estimated to lead the global market by securing a significant CAGR during the forecast period. Due to surging respiratory diseases, the testing equipment for infectious illnesses is significantly growing, which results in indriving market growth. According to a report by LANCET, in 2019, nearly 17.2 billion cases related to upper respiratory infections were there around the globe. These factors are expanding the global market by increasing sales.&
RT-PCR Category Dominating the Market in the Technology Segment
Based on technology, the RT-PCR category is leading the global market by securing a CAGR of 9.2% during the forecast period. Due to increasing several testing, including COVID-19, proteomics and genomics are rising the adoption of RT-PCR. The demand for RT-PCR is continuously growing due to cost efficiency, high sensitivity, and low time consumption.&
The demand for RT-PCR is increasing for several other infections, such as Ebola, which favours market opportunities. Historically, the RT-PCR secured a CAGR of 9.6% between 2017 and 2022.
Hospitals & ICUs Segment Drives the Point-of-Care Molecular Diagnostics Market?
Based on end users,&the hospitals & ICUs&segment registered a huge revenue by securing a significant share during the forecast period. Soaring diseases, patient population, and advanced technology testing equipment are driving the hospitals & ICUs segment. The increasing adoption of point-of-care molecular testing by healthcare providers to detect accurate diseases in hospitals & ICUs is surging the market opportunities.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Top Countries Data Table Mentioned Below
| Countries | United States |
| CAGR (2017 to 2022) | 12.2% |
| CAGR (2023 to 2033) | 9.5% |
| Valuation (2023 to 2033) | US$ 3.9 billion |
| Countries | United Kingdom |
| CAGR (2017 to 2022) | 11.2% |
| CAGR (2023 to 2033) | 8.8% |
| Valuation (2023 to 2033) | US$ 467.1 million |
| Countries | China |
| CAGR (2017 to 2022) | 11.8% |
| CAGR (2023 to 2033) | 9.1% |
| Valuation (2023 to 2033) | US$ 796.5 million |
| Countries | Japan |
| CAGR (2017 to 2022) | 10.7% |
| CAGR (2023 to 2033) | 8.2% |
| Valuation (2023 to 2033) | US$ 651 million |
| Countries | South Korea |
| CAGR (2017 to 2022) | 9.3% |
| CAGR (2023 to 2033) | 7.4% |
| Valuation (2023 to 2033) | US$ 383 million |
Favorable Government Support Boosts the United States Market
The United States is to capture a significant portion of the global market by securing a CAGR of 9.5% with a valuation of US$ 3.9 billion during the forecast period. Rising research & development activities, innovation of advanced products, presence of key players, and government initiatives are expanding the United States' point-of-care molecular diagnostics market.
The increase of several chronic diseases, novel products, and prominent expansion in the healthcare sector surged the United States market opportunities. In North America, in 2020, the market surged at a valuation of US$ 1.4 billion. Rising early-stage infectious, POC testing and increasing COVID-19 tests in recent years are expanding the market opportunities in the United States. Historically, the United States secured a CAGR of 12.2% between 2017 and 2022.
Why is Demand for Point-of-Care Molecular Diagnostics rising Across the United Kingdom?
The United Kingdom is registering a CAGR of 8.8% with a valuation of US$ 467.8 million during the forecast period. Rising healthcare infrastructure, urbanization, research & development activities, and huge investments by the government are driving market opportunities in the United Kingdom.
Growing demand for point-of-care molecular PCR to detect chronic and infectious diseases fuels the market size. According to Cancer Research United Kingdom, around 375400 new cancer cases were recorded in the United Kingdom between 2016 and 2018. Historically, the United Kingdom captured a CAGR of 11.2% between 2017 and 2022.
Laboratory Testing Services Surge China Market Size?
China is one of the significant contributors to the Asia-Pacific market. China is securing a CAGR of 9.1% with a valuation of US$ 796.5 million during the forecast period. The increasing number of testing laboratories, clinical testing, and large population is expanding the market growth.
Rising cost-effective and advanced testing boosts the demand for point-of-care molecular diagnostics in China. China's point-of-care molecular diagnostics market historically captured a CAGR of 11.8% between 2017 and 2022.
Competitive Landscape
The number of key marketers uplifts the global market by playing a significant role. These players focus on developing innovative products to enhance the healthcare sector. Their new ideas, tactics, and deep market research welcome better products in the global market.
The distribution channels and innovative advanced novel technology products upsurge the market at another height. Apart from it, they adopted a few marketing strategies such as mergers, partnerships, acquisitions, collaborations, and agreements.
Other Prominent Playersin the Market are
- Abbott Laboratories
- Hoffmann-La Roche Ltd.
- BioMérieux S.A.
- Danaher Corporation
- Quidel Corporation
- QIAGEN N.V.
- Co-Diagnostics, Inc.
- Biocartis NV (Belgium)
- Meridian Bioscience, Inc.
- Thermo Fisher Scientific, Inc.
Recent Developments:
- In Mar 2020, Abbott Laboratories launched its new point of care for COVID-19 detection.
- In July 2021, QuantuMDxintroduced its quick point-of-care PCR system for detecting Q-POC diagnoses.
- In 2022, a molecular diagnostics company- Co-Diagnostics, acquired Idaho Molecular.
- In Oct 2020, BioMérieux partnered with Africa Medical Supplies Platform to provide high-quality diagnostics solutions for COVID-19.
- In Oct 2018, QIAGEN negotiated with STAT-Dx to enhance its portfolio in testing solutions for next-gen PCR systems.
Scope of Report
|
Attribute |
Details |
|
Forecast Period |
2023 to 2033 |
|
Historical Data Available for |
2017 to 2022 |
|
Market Analysis |
US$ billion for Value |
|
Key Countries Covered |
United States, Canada, Germany, United Kingdom., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Northern Africa,South Africa, and Türkiye |
|
Key Segments Covered |
|
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Point-of-care Molecular Diagnostics Market Segmentation by Category
By Products & Services:
- Assays & Kits
- Instruments &Analyzers
- Software & Services
By Technology:
- RT-PCR
- INAAT
- Other Technologies
By Application:
- Respiratory Diseases
- Sexually Transmitted Diseases
- Hospital-acquired Infections
- Cancer
- Hepatitis
- Gastrointestinal Disorders
- Other Applications
By End User:
- Physicians’ Offices
- Hospitals & ICUs
- Research Institutes
- Other End Users
By Region:
- North America
- Latin America
- Europe
- South Asia & Pacific
- East Asia
- The Middle East & Africa (MEA)
Frequently Asked Questions
The point-of-care molecular diagnostics market is predicted to secure a 9.7% CAGR through 2033.
The hospital sector drives the point-of-care molecular diagnostics market.
The point-of-care molecular diagnostics market is expected to surpass US$ 11.1 billion by 2033.
The point-of-care molecular diagnostics market is anticipated to be US$ 4.4 billion in 2023.
The United States leads the point-of-care molecular diagnostics market during the forecast period.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product & Service
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product & Service, 2017 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product & Service, 2023 to 2033
5.3.1. Assays & kits
5.3.2. Instruments & Analyzers
5.3.3. Software & Services
5.4. Y-o-Y Growth Trend Analysis By Product & Service, 2017 to 2022
5.5. Absolute $ Opportunity Analysis By Product & Service, 2023 to 2033
6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Technology
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2017 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2023 to 2033
6.3.1. RT-PCR
6.3.2. INAAT
6.3.3. Other Technologies
6.4. Y-o-Y Growth Trend Analysis By Technology, 2017 to 2022
6.5. Absolute $ Opportunity Analysis By Technology, 2023 to 2033
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Application , 2017 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application , 2023 to 2033
7.3.1. Respiratory Diseases
7.3.2. Sexually Transmitted Diseases
7.3.3. Hospital-acquired Infections
7.3.4. Cancer
7.3.5. Hepatitis
7.3.6. Gastrointestinal Disorders
7.3.7. Other Applications
7.4. Y-o-Y Growth Trend Analysis By Application , 2017 to 2022
7.5. Absolute $ Opportunity Analysis By Application , 2023 to 2033
8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2022
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033
8.3.1. Physicians Offices
8.3.2. Hospitals & ICUs
8.3.3. Research Institutes
8.3.4. Other End Users
8.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022
8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022
9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia Pacific
9.3.5. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. USA
10.2.1.2. Canada
10.2.2. By Product & Service
10.2.3. By Technology
10.2.4. By Application
10.2.5. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product & Service
10.3.3. By Technology
10.3.4. By Application
10.3.5. By End User
10.4. Key Takeaways
11. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Product & Service
11.2.3. By Technology
11.2.4. By Application
11.2.5. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product & Service
11.3.3. By Technology
11.3.4. By Application
11.3.5. By End User
11.4. Key Takeaways
12. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. United kingdom
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Rest of Europe
12.2.2. By Product & Service
12.2.3. By Technology
12.2.4. By Application
12.2.5. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product & Service
12.3.3. By Technology
12.3.4. By Application
12.3.5. By End User
12.4. Key Takeaways
13. Asia Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.1.4. Thailand
13.2.1.5. Singapore
13.2.1.6. Australia
13.2.1.7. Rest of Asia Pacific
13.2.2. By Product & Service
13.2.3. By Technology
13.2.4. By Application
13.2.5. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product & Service
13.3.3. By Technology
13.3.4. By Application
13.3.5. By End User
13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of Middle East and Africa
14.2.2. By Product & Service
14.2.3. By Technology
14.2.4. By Application
14.2.5. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product & Service
14.3.3. By Technology
14.3.4. By Application
14.3.5. By End User
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Product & Service
15.1.2.2. By Technology
15.1.2.3. By Application
15.1.2.4. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Product & Service
15.2.2.2. By Technology
15.2.2.3. By Application
15.2.2.4. By End User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Product & Service
15.3.2.2. By Technology
15.3.2.3. By Application
15.3.2.4. By End User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Product & Service
15.4.2.2. By Technology
15.4.2.3. By Application
15.4.2.4. By End User
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Product & Service
15.5.2.2. By Technology
15.5.2.3. By Application
15.5.2.4. By End User
15.6. United kingdom
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Product & Service
15.6.2.2. By Technology
15.6.2.3. By Application
15.6.2.4. By End User
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Product & Service
15.7.2.2. By Technology
15.7.2.3. By Application
15.7.2.4. By End User
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Product & Service
15.8.2.2. By Technology
15.8.2.3. By Application
15.8.2.4. By End User
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Product & Service
15.9.2.2. By Technology
15.9.2.3. By Application
15.9.2.4. By End User
15.10. China
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Product & Service
15.10.2.2. By Technology
15.10.2.3. By Application
15.10.2.4. By End User
15.11. Japan
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Product & Service
15.11.2.2. By Technology
15.11.2.3. By Application
15.11.2.4. By End User
15.12. South Korea
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Product & Service
15.12.2.2. By Technology
15.12.2.3. By Application
15.12.2.4. By End User
15.13. Thailand
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Product & Service
15.13.2.2. By Technology
15.13.2.3. By Application
15.13.2.4. By End User
15.14. Singapore
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Product & Service
15.14.2.2. By Technology
15.14.2.3. By Application
15.14.2.4. By End User
15.15. Australia
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Product & Service
15.15.2.2. By Technology
15.15.2.3. By Application
15.15.2.4. By End User
15.16. GCC Countries
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Product & Service
15.16.2.2. By Technology
15.16.2.3. By Application
15.16.2.4. By End User
15.17. South Africa
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2022
15.17.2.1. By Product & Service
15.17.2.2. By Technology
15.17.2.3. By Application
15.17.2.4. By End User
15.18. Israel
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2022
15.18.2.1. By Product & Service
15.18.2.2. By Technology
15.18.2.3. By Application
15.18.2.4. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Product & Service
16.3.3. By Technology
16.3.4. By Application
16.3.5. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Abbott Laboratories
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. F. Hoffmann-La Roche Ltd.
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. bioMérieux S.A.
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. Danaher Corporation
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. Quidel Corporation
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. QIAGEN N.V.
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Co-Diagnostics, Inc.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Biocartis NV
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. Meridian Bioscience, Inc.
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. Thermo Fisher Scientific
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2033
Table 2: Global Market Value (US$ Million) Forecast by Product & Service, 2017 to 2033
Table 3: Global Market Value (US$ Million) Forecast by Technology, 2017 to 2033
Table 4: Global Market Value (US$ Million) Forecast by Application , 2017 to 2033
Table 5: Global Market Value (US$ Million) Forecast by End User, 2017 to 2033
Table 6: North America Market Value (US$ Million) Forecast by Country, 2017 to 2033
Table 7: North America Market Value (US$ Million) Forecast by Product & Service, 2017 to 2033
Table 8: North America Market Value (US$ Million) Forecast by Technology, 2017 to 2033
Table 9: North America Market Value (US$ Million) Forecast by Application , 2017 to 2033
Table 10: North America Market Value (US$ Million) Forecast by End User, 2017 to 2033
Table 11: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2033
Table 12: Latin America Market Value (US$ Million) Forecast by Product & Service, 2017 to 2033
Table 13: Latin America Market Value (US$ Million) Forecast by Technology, 2017 to 2033
Table 14: Latin America Market Value (US$ Million) Forecast by Application , 2017 to 2033
Table 15: Latin America Market Value (US$ Million) Forecast by End User, 2017 to 2033
Table 16: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2033
Table 17: Europe Market Value (US$ Million) Forecast by Product & Service, 2017 to 2033
Table 18: Europe Market Value (US$ Million) Forecast by Technology, 2017 to 2033
Table 19: Europe Market Value (US$ Million) Forecast by Application , 2017 to 2033
Table 20: Europe Market Value (US$ Million) Forecast by End User, 2017 to 2033
Table 21: Asia Pacific Market Value (US$ Million) Forecast by Country, 2017 to 2033
Table 22: Asia Pacific Market Value (US$ Million) Forecast by Product & Service, 2017 to 2033
Table 23: Asia Pacific Market Value (US$ Million) Forecast by Technology, 2017 to 2033
Table 24: Asia Pacific Market Value (US$ Million) Forecast by Application , 2017 to 2033
Table 25: Asia Pacific Market Value (US$ Million) Forecast by End User, 2017 to 2033
Table 26: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2017 to 2033
Table 27: Middle East and Africa Market Value (US$ Million) Forecast by Product & Service, 2017 to 2033
Table 28: Middle East and Africa Market Value (US$ Million) Forecast by Technology, 2017 to 2033
Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Application , 2017 to 2033
Table 30: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2017 to 2033
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Market Value (US$ Million) by Product & Service, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by Technology, 2023 to 2033
Figure 3: Global Market Value (US$ Million) by Application , 2023 to 2033
Figure 4: Global Market Value (US$ Million) by End User, 2023 to 2033
Figure 5: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 6: Global Market Value (US$ Million) Analysis by Region, 2017 to 2033
Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 9: Global Market Value (US$ Million) Analysis by Product & Service, 2017 to 2033
Figure 10: Global Market Value Share (%) and BPS Analysis by Product & Service, 2023 to 2033
Figure 11: Global Market Y-o-Y Growth (%) Projections by Product & Service, 2023 to 2033
Figure 12: Global Market Value (US$ Million) Analysis by Technology, 2017 to 2033
Figure 13: Global Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033
Figure 14: Global Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033
Figure 15: Global Market Value (US$ Million) Analysis by Application , 2017 to 2033
Figure 16: Global Market Value Share (%) and BPS Analysis by Application , 2023 to 2033
Figure 17: Global Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033
Figure 18: Global Market Value (US$ Million) Analysis by End User, 2017 to 2033
Figure 19: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 20: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 21: Global Market Attractiveness by Product & Service, 2023 to 2033
Figure 22: Global Market Attractiveness by Technology, 2023 to 2033
Figure 23: Global Market Attractiveness by Application , 2023 to 2033
Figure 24: Global Market Attractiveness by End User, 2023 to 2033
Figure 25: Global Market Attractiveness by Region, 2023 to 2033
Figure 26: North America Market Value (US$ Million) by Product & Service, 2023 to 2033
Figure 27: North America Market Value (US$ Million) by Technology, 2023 to 2033
Figure 28: North America Market Value (US$ Million) by Application , 2023 to 2033
Figure 29: North America Market Value (US$ Million) by End User, 2023 to 2033
Figure 30: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 31: North America Market Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 34: North America Market Value (US$ Million) Analysis by Product & Service, 2017 to 2033
Figure 35: North America Market Value Share (%) and BPS Analysis by Product & Service, 2023 to 2033
Figure 36: North America Market Y-o-Y Growth (%) Projections by Product & Service, 2023 to 2033
Figure 37: North America Market Value (US$ Million) Analysis by Technology, 2017 to 2033
Figure 38: North America Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033
Figure 39: North America Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033
Figure 40: North America Market Value (US$ Million) Analysis by Application , 2017 to 2033
Figure 41: North America Market Value Share (%) and BPS Analysis by Application , 2023 to 2033
Figure 42: North America Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033
Figure 43: North America Market Value (US$ Million) Analysis by End User, 2017 to 2033
Figure 44: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 45: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 46: North America Market Attractiveness by Product & Service, 2023 to 2033
Figure 47: North America Market Attractiveness by Technology, 2023 to 2033
Figure 48: North America Market Attractiveness by Application , 2023 to 2033
Figure 49: North America Market Attractiveness by End User, 2023 to 2033
Figure 50: North America Market Attractiveness by Country, 2023 to 2033
Figure 51: Latin America Market Value (US$ Million) by Product & Service, 2023 to 2033
Figure 52: Latin America Market Value (US$ Million) by Technology, 2023 to 2033
Figure 53: Latin America Market Value (US$ Million) by Application , 2023 to 2033
Figure 54: Latin America Market Value (US$ Million) by End User, 2023 to 2033
Figure 55: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 56: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 59: Latin America Market Value (US$ Million) Analysis by Product & Service, 2017 to 2033
Figure 60: Latin America Market Value Share (%) and BPS Analysis by Product & Service, 2023 to 2033
Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Product & Service, 2023 to 2033
Figure 62: Latin America Market Value (US$ Million) Analysis by Technology, 2017 to 2033
Figure 63: Latin America Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033
Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033
Figure 65: Latin America Market Value (US$ Million) Analysis by Application , 2017 to 2033
Figure 66: Latin America Market Value Share (%) and BPS Analysis by Application , 2023 to 2033
Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033
Figure 68: Latin America Market Value (US$ Million) Analysis by End User, 2017 to 2033
Figure 69: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 70: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 71: Latin America Market Attractiveness by Product & Service, 2023 to 2033
Figure 72: Latin America Market Attractiveness by Technology, 2023 to 2033
Figure 73: Latin America Market Attractiveness by Application , 2023 to 2033
Figure 74: Latin America Market Attractiveness by End User, 2023 to 2033
Figure 75: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 76: Europe Market Value (US$ Million) by Product & Service, 2023 to 2033
Figure 77: Europe Market Value (US$ Million) by Technology, 2023 to 2033
Figure 78: Europe Market Value (US$ Million) by Application , 2023 to 2033
Figure 79: Europe Market Value (US$ Million) by End User, 2023 to 2033
Figure 80: Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 81: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 84: Europe Market Value (US$ Million) Analysis by Product & Service, 2017 to 2033
Figure 85: Europe Market Value Share (%) and BPS Analysis by Product & Service, 2023 to 2033
Figure 86: Europe Market Y-o-Y Growth (%) Projections by Product & Service, 2023 to 2033
Figure 87: Europe Market Value (US$ Million) Analysis by Technology, 2017 to 2033
Figure 88: Europe Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033
Figure 89: Europe Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033
Figure 90: Europe Market Value (US$ Million) Analysis by Application , 2017 to 2033
Figure 91: Europe Market Value Share (%) and BPS Analysis by Application , 2023 to 2033
Figure 92: Europe Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033
Figure 93: Europe Market Value (US$ Million) Analysis by End User, 2017 to 2033
Figure 94: Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 95: Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 96: Europe Market Attractiveness by Product & Service, 2023 to 2033
Figure 97: Europe Market Attractiveness by Technology, 2023 to 2033
Figure 98: Europe Market Attractiveness by Application , 2023 to 2033
Figure 99: Europe Market Attractiveness by End User, 2023 to 2033
Figure 100: Europe Market Attractiveness by Country, 2023 to 2033
Figure 101: Asia Pacific Market Value (US$ Million) by Product & Service, 2023 to 2033
Figure 102: Asia Pacific Market Value (US$ Million) by Technology, 2023 to 2033
Figure 103: Asia Pacific Market Value (US$ Million) by Application , 2023 to 2033
Figure 104: Asia Pacific Market Value (US$ Million) by End User, 2023 to 2033
Figure 105: Asia Pacific Market Value (US$ Million) by Country, 2023 to 2033
Figure 106: Asia Pacific Market Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 107: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 108: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 109: Asia Pacific Market Value (US$ Million) Analysis by Product & Service, 2017 to 2033
Figure 110: Asia Pacific Market Value Share (%) and BPS Analysis by Product & Service, 2023 to 2033
Figure 111: Asia Pacific Market Y-o-Y Growth (%) Projections by Product & Service, 2023 to 2033
Figure 112: Asia Pacific Market Value (US$ Million) Analysis by Technology, 2017 to 2033
Figure 113: Asia Pacific Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033
Figure 114: Asia Pacific Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033
Figure 115: Asia Pacific Market Value (US$ Million) Analysis by Application , 2017 to 2033
Figure 116: Asia Pacific Market Value Share (%) and BPS Analysis by Application , 2023 to 2033
Figure 117: Asia Pacific Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033
Figure 118: Asia Pacific Market Value (US$ Million) Analysis by End User, 2017 to 2033
Figure 119: Asia Pacific Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 120: Asia Pacific Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 121: Asia Pacific Market Attractiveness by Product & Service, 2023 to 2033
Figure 122: Asia Pacific Market Attractiveness by Technology, 2023 to 2033
Figure 123: Asia Pacific Market Attractiveness by Application , 2023 to 2033
Figure 124: Asia Pacific Market Attractiveness by End User, 2023 to 2033
Figure 125: Asia Pacific Market Attractiveness by Country, 2023 to 2033
Figure 126: Middle East and Africa Market Value (US$ Million) by Product & Service, 2023 to 2033
Figure 127: Middle East and Africa Market Value (US$ Million) by Technology, 2023 to 2033
Figure 128: Middle East and Africa Market Value (US$ Million) by Application , 2023 to 2033
Figure 129: Middle East and Africa Market Value (US$ Million) by End User, 2023 to 2033
Figure 130: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033
Figure 131: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 132: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 133: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 134: Middle East and Africa Market Value (US$ Million) Analysis by Product & Service, 2017 to 2033
Figure 135: Middle East and Africa Market Value Share (%) and BPS Analysis by Product & Service, 2023 to 2033
Figure 136: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product & Service, 2023 to 2033
Figure 137: Middle East and Africa Market Value (US$ Million) Analysis by Technology, 2017 to 2033
Figure 138: Middle East and Africa Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033
Figure 139: Middle East and Africa Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033
Figure 140: Middle East and Africa Market Value (US$ Million) Analysis by Application , 2017 to 2033
Figure 141: Middle East and Africa Market Value Share (%) and BPS Analysis by Application , 2023 to 2033
Figure 142: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033
Figure 143: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2017 to 2033
Figure 144: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 145: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 146: Middle East and Africa Market Attractiveness by Product & Service, 2023 to 2033
Figure 147: Middle East and Africa Market Attractiveness by Technology, 2023 to 2033
Figure 148: Middle East and Africa Market Attractiveness by Application , 2023 to 2033
Figure 149: Middle East and Africa Market Attractiveness by End User, 2023 to 2033
Figure 150: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
